A new report found some 16 million Americans of working age have long COVID and about 2 to 4 million are not working as they struggle with their symptoms.
Some 16 million Americans of working age have long-term COVID and as many as 4 million are not working as they struggle with their symptoms, according to a new report from the Brookings Institution.
The pace at which the economic burden will grow depends on three factors, according to the report: the availability and accessibility of improved treatments that help move long COVID patients from severely ill to mildly ill; whether vaccines help in preventing long COVID; and whether repeat infections carry additional long-COVID risk.
The daily average for new cases stood at 91,400 on Thursday, according to a New York Times tracker, down 14% from two weeks ago. The daily average for hospitalizations was down 9% at 39,071, while the daily average for deaths is down 3% to 460. “This groundbreaking technology was critical to the development of Moderna’s own mRNA COVID-19 vaccine, Spikevax,” the company said in a statement. “Pfizer and BioNTech copied this technology, without Moderna’s permission, to make Comirnaty,” said the statement, referring to the Pfizer-BioNTech vaccine.
• Tennis star Novak Djokovic will miss the 2022 U.S. Open due to his vaccination status, MarketWatch’s Weston Blasi noted. Djokovic announced the news on Twitter on Thursday morning while saying he will “keep in good shape and positive spirit and wait for an opportunity to compete again.”
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna to sue BioNTech/Pfizer over COVID vaccineModerna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said.
Weiterlesen »
Moderna sues Pfizer, BioNTech over COVID-19 vaccine patentsCOVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.
Weiterlesen »
Moderna Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID VaccineModerna announced Friday it is suing Pfizer and its German partner BioNTech, alleging the two companies copied Moderna’s technology in its development of their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax. “We…
Weiterlesen »
Moderna suing Pfizer over Covid vaccine technologyModerna said it is suing Pfizer and its German partner BioNTech for patent infringement.
Weiterlesen »
Moderna suing Pfizer over vaccine technologyModerna said it’s suing Pfizer and BioNTech over alleged patent infringements, the company announced Friday.
Weiterlesen »
Moderna files patent infringement lawsuits against Pfizer and BioNTech over mRNA Covid-19 vaccinesModerna on Friday filed patent infringement lawsuits against Pfizer and BioNTech 'for infringing patents central to (its) mRNA technology platform,' the company said in a news release Friday.
Weiterlesen »